By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Response Genetics today said that it has regained compliance with the Nasdaq Capital Market's rule covering the minimum market value of listed securities.

The Los Angeles-based molecular diagnostics developer said that it was notified by Nasdaq on Feb. 16 that it had regained compliance and the "delisting matter is now closed."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.